Ozempic Plateau: Why GLP-1 Weight Loss Stalls and What to Do Next

Most people on Ozempic, Wegovy, or Mounjaro see significant weight loss in the first few months. Then it slows. Then it stops. This is not the medication failing — it is a predictable phase of GLP-1-assisted weight loss, and understanding why it happens makes it easier to manage.

Why the plateau happens

Metabolic adaptation. As body weight decreases, resting metabolic rate decreases too. A lighter body burns fewer calories at rest. This is a fundamental physiological response to weight loss, not specific to GLP-1s. The larger the weight loss, the more pronounced this effect.

The body defends its weight. Beyond calorie math, the body has regulatory mechanisms that resist weight loss — increasing hunger signals, reducing non-exercise activity thermogenesis (fidgeting, posture, spontaneous movement), and increasing the efficiency of calorie use. GLP-1 medications suppress appetite powerfully, but they don't eliminate all of these compensatory responses.

Appetite suppression can plateau too. For some people, the appetite-suppressing effect of their dose becomes less pronounced over time. This is not universal, but it does happen and can contribute to a stall.

Muscle loss lowering the metabolic floor. If significant muscle has been lost during weight loss (which happens when protein intake is inadequate and resistance training is absent), resting metabolic rate drops further than body weight alone would predict. This accelerates plateauing.

What doesn't help

Cutting calories further when already eating very little. This typically worsens muscle loss without breaking the plateau, and creates a metabolic environment that makes long-term maintenance harder.

What actually helps

Resistance training. This is the highest-leverage intervention at a plateau. Adding or increasing resistance training does two things: it burns calories, and it builds or preserves muscle, which raises resting metabolic rate. A small increase in muscle mass can shift the metabolic floor enough to break a stall without eating less.

Protein review. At a plateau, most people find they are eating less protein than they think. Track intake for a week and compare to a target of 1.2–1.6g per kg of bodyweight. Increasing protein within the same calorie budget often restores muscle mass and helps break the plateau.

Activity volume, not just intensity. Non-exercise activity — walking, standing, daily movement — accounts for a significant share of total calorie expenditure. Increasing daily steps from 4,000 to 8,000 can add several hundred calories of expenditure per day without structured exercise.

Dose adjustment (with your prescriber). If appetite suppression has genuinely faded, discussing dose adjustment with your prescribing doctor is appropriate. This is not "giving up" — it is using the medication correctly.

Diet structure, not restriction. A protein-first approach at meals (eat protein before vegetables and carbs) helps maintain muscle while keeping total intake manageable.

For a full framework covering nutrition, muscle retention, and training structure while on a GLP-1 medication: What to Eat on Ozempic or Wegovy — Guide Crafted.